Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Titel:
Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Auteur:
Moreno, V. Gil-Martin, M. Johnson, M.L. Aljumaily, R. Lopez Criado, P. Northfelt, D.W. Crittenden, M. Jabbour, S. Rosen, L. Garrido, P. Hervás Morón, A. Rietschel, P. Mohan, K.K. Li, J. Stankevich, E. Feng, M. Lowy, I. Fury, M.G.